- Home
- REGCP vs IMNM Comparison
REGCP vs IMNM Comparison
Compare REGCP & IMNM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- REGCP
- IMNM
- Stock Information
- Founded
- REGCP N/A
- IMNM 2006
- Country
- REGCP United States
- IMNM United States
- Employees
- REGCP 497
- IMNM N/A
- Industry
- REGCP
- IMNM Medicinal Chemicals and Botanical Products
- Sector
- REGCP
- IMNM Health Care
- Exchange
- REGCP Nasdaq
- IMNM Nasdaq
- Market Cap
- REGCP N/A
- IMNM 747.7M
- IPO Year
- REGCP N/A
- IMNM 2020
- Fundamental
- Price
- REGCP $23.61
- IMNM $10.97
- Analyst Decision
- REGCP
- IMNM Strong Buy
- Analyst Count
- REGCP 0
- IMNM 5
- Target Price
- REGCP N/A
- IMNM $28.60
- AVG Volume (30 Days)
- REGCP N/A
- IMNM 911.8K
- Earning Date
- REGCP N/A
- IMNM 11-13-2024
- Dividend Yield
- REGCP N/A
- IMNM N/A
- EPS Growth
- REGCP N/A
- IMNM N/A
- EPS
- REGCP N/A
- IMNM N/A
- Revenue
- REGCP N/A
- IMNM $10,129,000.00
- Revenue This Year
- REGCP N/A
- IMNM N/A
- Revenue Next Year
- REGCP N/A
- IMNM N/A
- P/E Ratio
- REGCP N/A
- IMNM N/A
- Revenue Growth
- REGCP N/A
- IMNM N/A
- 52 Week Low
- REGCP N/A
- IMNM $8.33
- 52 Week High
- REGCP N/A
- IMNM $30.96
- Technical
- Relative Strength Index (RSI)
- REGCP 36.71
- IMNM 39.61
- Support Level
- REGCP $23.34
- IMNM $10.76
- Resistance Level
- REGCP $23.60
- IMNM $15.13
- Average True Range (ATR)
- REGCP 0.25
- IMNM 0.98
- MACD
- REGCP -0.05
- IMNM -0.29
- Stochastic Oscillator
- REGCP 28.18
- IMNM 4.81
About REGCP Regency Centers Corporation
Regency Centers is one of the largest shopping center-focused retail REITs. The company's portfolio includes an interest in 483 properties, which includes over 57 million square feet of retail space following the completion of the Urstadt Biddle acquisition in August 2023. The portfolio is geographically diversified with 22 regional offices and no single market representing more than 12% of total company net operating income. Regency's retail portfolio is primarily composed of grocery-anchored centers, with 80% of properties featuring a grocery anchor and grocery stores representing 20% of annual base rent.
About IMNM Immunome Inc.
Immunome Inc is a biopharmaceutical company. It is engaged in utilizing a proprietary human memory B cell platform to discover and develop first-in-class antibody therapeutics designed to change the way diseases are currently being treated. The objective of the company is to establish a broad pipeline of preclinical and clinical assets which itcan efficiently develop through successive value inflection points. The company's primary focus areas are oncology and infectious disease, including COVID-19. It operates in the U.S. Its current pipelines comprise IM-1021, a fibroblast activation protein (FAP) and and IM-4320.